ESH/LinkedIn
Apr 27, 2026, 15:38
Key Insights from ESHMPN 26 on Advances in MPN Management – ESH
The European School of Haematology (ESH) shared a post on LinkedIn:
“Today’s second ESHMPN 26 session chaired by Jean – Jacques Kiladjian (INSERM) focussed on MPN management.
Marta Sobas (Collegium Medicum Uniwersytetu Mikołaja Kopernika) on the role of interferons on haematological and molecular responses;
- Jennifer O’Sullivan (Guy’s and St Thomas’ NHS Foundation Trust) on new potential trial endpoints;
- Chloé James (CHU de Bordeaux) on how to prevent thrombosis and bleeding in MPN;
- Selected brief oral presentation by Chiara Carretta, (Centro di Medicina Estetica e Rigenerativa) on determinants of JAK inhibitor efficacy in myelofibrosis revealed by Multiomic Single-Cell Analysis
Stay tuned!
For a deeper insight, meet Marta Sobas, Jennifer O’Sullivan, or Chloé James at tomorrow’s meeting the expert session!”
Stay updated with Hemostasis Today.
-
Apr 27, 2026, 16:04Heghine Khachatryan: Intracranial Hemorrhage in Leukemia – Beyond Thrombocytopenia
-
Apr 27, 2026, 15:56Marc Carrier: Supporting Thrombosis Canada in My Final Year as President
-
Apr 27, 2026, 15:52Tagreed Alkaltham։ You Think Eligibility Is About You… It’s Not
-
Apr 27, 2026, 15:52Emma Gasson: Top Abstract Oral Presentation at BSH 2026 on Cancer-Associated Thrombosis Microfluidics
-
Apr 27, 2026, 15:48Elliot Tapper: Continuing Anticoagulation Improves PVT Outcomes During Banding
-
Apr 27, 2026, 15:44Crisanto Torres: Early Plasma Administration Maximizes Survival in Traumatic Intracranial Hemorrhage
-
Apr 27, 2026, 15:30Shahid Gilani: Risk of Thrombosis in Central Venous Catheters in Cancer Patients
-
Apr 27, 2026, 15:24Anirban Sen Gupta: PlateChek Microsensor for Rapid Coagulation Testing
-
Apr 27, 2026, 15:04Tareq Abadl։ Why You Should Never Separate Serum Before Clotting Is Complete